DAX23.966 +0,2%ESt505.342 -0,3%Top 10 Crypto13,94 +0,3%Dow42.305 +0,1%Nas19.243 +0,7%Bitcoin92.111 -0,4%Euro1,1412 -0,3%Öl64,72 -0,6%Gold3.360 -0,6%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Rheinmetall 703000 RENK RENK73 HENSOLDT HAG000 BioNTech (ADRs) A2PSR2 NVIDIA 918422 Gerresheimer A0LD6E Tesla A1CX3T Siemens Energy ENER6Y BYD A0M4W9 Lufthansa 823212 Bayer BAY001 Mercedes-Benz Group (ex Daimler) 710000 BASF BASF11 thyssenkrupp 750000 Deutsche Bank 514000
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
DAX stabil -- Weißes Haus stellt Telefonat von Trump und Xi in Aussicht -- Rheinmetall ersetzt Kering im EuroStoxx 50 -- BYD tritt Preiskampf los -- BioNTech, Palantir im Fokus
Top News
Zalando-Aktie erhält von RBC Capital Markets Bewertung: Outperform Zalando-Aktie erhält von RBC Capital Markets Bewertung: Outperform
Snowflake übernimmt Crunchy Data für 250 Mio. USD Snowflake übernimmt Crunchy Data für 250 Mio. USD
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

Phio Pharmaceuticals Aktie

Handeln
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!
JETZT LOSLEGEN
Bei einem anderen Broker handelnSmartphone
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKNA2PYB0

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS71880W3034

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolPHIO

Phio Pharmaceuticals Aktien News

DatumMeistgelesen
PR NewswirePhio Pharmaceuticals Announces Initiation of Collaborative Clinical Trial with PH-762, AgonOx's Tumor Infiltrating Lymphocyte Program (AGX148) and Providence Cancer Institute
PR NewswirePhio Pharmaceuticals Presents Preclinical Study Showing INTASYL™ Treatment of NK Cells More than Doubles Ability to Kill Tumor Cells
PR NewswirePhio Pharmaceuticals Announces FDA Clearance to Initiate Clinical Trial of PH-762 for Treatment of Skin Carcinomas
PR NewswirePhio Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Business Update
PR NewswirePhio Pharmaceuticals Announces $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
PR NewswirePhio Pharmaceuticals Presents Preclinical Data Demonstrating Synergy-Enhanced in vivo Anti-Tumor Efficacy of PD-1/CTLA-4 Dual-Targeting INTASYL
PR NewswirePhio Pharmaceuticals Presents Preclinical Study Showing PH-762 Induces Systemic Memory T Cell Mediators of Anti-Tumor Immunity
PR NewswirePhio Pharmaceuticals Reports 2022 Year End Financial Results and Provides Business Update
PR NewswirePhio Pharmaceuticals Appoints Robert Bitterman as President and Chief Executive Officer
PR NewswirePhio Pharmaceuticals Regains Compliance with Nasdaq Listing Requirements
PR NewswirePhio Pharmaceuticals Announces Positive DMC Recommendation and Continued Enrollment of Advanced Melanoma Study Without Modification
PR NewswirePhio Pharmaceuticals Announces Reverse Stock Split
PR NewswirePhio Showcases Innovations in Dermatology Cancers at 2023 Dermatology Summit in San Francisco
PR NewswirePhio Pharmaceuticals Announces Regulatory Clearance of Clinical Trial With PH-762 and AgonOx's Tumor Infiltrating Lymphocytes (AGX148) to Treat Solid Tumors
PR NewswirePhio Pharmaceuticals Announces New Clinical Program to Study PH-762 for the Treatment of Cutaneous Squamous Cell Carcinoma
PR NewswirePhio Announces New Appointments to Leadership Team, Reports on Third Quarter 2022 Financial Results and Provides Business Update
PR NewswirePhio Pharmaceuticals Announces Study Results at the 37th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) on November 10th and 11th
PR NewswirePhio Pharmaceuticals Announces Upcoming Presentations at the 37th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
PR NewswirePhio Pharmaceuticals Announces Appointment of Robert Bitterman as Executive Chairman
PR NewswirePhio Pharmaceuticals Announces Preclinical Data Demonstrating PH-762 Enhances Persistence of T cells for Tumor Cell Killing as Presented by Helmholtz Munich at the 9th Immunotherapy of Cancer Conf...
PR NewswirePhio Pharmaceuticals Announces Acceptance of Six Abstracts at The 37th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
PR NewswirePhio Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update
PR NewswirePhio Pharmaceuticals Presents Study Outline of Its First Clinical Trial with PH-762 for Advanced Melanoma at the 2022 ASCO Annual Meeting
Wer­bung

Phio Pharmaceuticals News

Phio Pharmaceuticals News: auf dieser Seite finden Sie alle Phio Pharmaceuticals News und Nachrichten zur Phio Pharmaceuticals Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Phio Pharmaceuticals News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Phio Pharmaceuticals News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.